BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celladon Corporation 

c/o Enterprise Partners Venture Capital
2223 Avenida de la Playa, Suite 300
La Jolla  California  92037  U.S.A.
Phone: 858-731-0241 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure 10/27/2014 8:16:25 AM
Celladon Corporation To Present At The 2014 Stem Cell Meeting On The Mesa 10/2/2014 7:52:31 AM
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning 9/22/2014 7:56:05 AM
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014 6:54:19 AM
Celladon Corporation Announces Pricing Of Public Offering Of Common Stock 8/13/2014 7:16:40 AM
Celladon Corporation Announces Trial To Investigate MYDICAR In Patients With Heart Failure And LVAD 8/11/2014 11:59:54 AM
Celladon Corporation Announces Initiation Of Clinical Trial To Investigate MYDICAR In Patients With Heart Failure And A Left Ventricular Assist Device (LVAD) 8/11/2014 7:28:29 AM
Celladon Corporation Reports Second Quarter 2014 Financial Results And Recent Highlights 8/7/2014 8:02:35 AM
Celladon Corporation Announces Commencement Of Public Offering Of Common Stock 8/7/2014 8:01:27 AM
Celladon Corporation Secures $25 Million Credit Facility From Hercules Growth Capital 8/1/2014 11:12:48 AM
12345678